Connect with us

Announcements

Leading Edge Pharms Welcomes NBA Champion John Salley as New EVP of Marketing

Published

on

Leading Edge Pharms Welcomes NBA Champion John Salley as New EVP of Marketing
  • Leading Edge Pharms hired a new EVP.
  • This EVP will take over marketing for their CANNAVERA line of products.

Leading Edge Pharms is a company centered around biotechnology, working to create new CBD therapies. In their latest efforts, PR Newswire reports that they’ve found a new executive vice president of marketing – John Salley. Salley, a four-time NBA champion and advocate of cannabis, will take over this role immediately.

Salley’s role will be to handle the new line of CBD-based topical solutions for pain and inflammation called CANNAVERA. In a statement from the new EVP, he expressed that he’s personally used the oils for pain, and he is looking forward to joining the team. David Chadwick, the CEO of Leading Edge, discussed the import role that CBD could play in the sports pain relief market.

The full press release can be viewed at prnewswire.com/news-releases/four-time-nba-champion-john-salley-joins-leading-edge-pharms-as-evp-of-marketing-300892140.html.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.